Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

83.85

+0.12 (0.14%)

Jul 27, 2026, 4:00 PM EDT - Market closed

Crinetics Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	8,841	4,449	4,751	2,426	986	1,352
Market Cap Growth	204.54%	-6.36%	95.88%	146.02%	-27.09%	190.40%
Enterprise Value	7,598	3,470	3,449	1,919	654.6	1,022
Last Close Price	83.85	46.55	51.13	35.58	18.30	28.41

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	489.30	578.10	4572.96	604.45	208.14	1254.39
PB Ratio	6.90	4.48	3.59	4.50	3.12	4.07
P/TBV Ratio	6.34	4.41	3.12	3.83	3.01	3.29

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	420.48	450.84	3319.50	478.16	138.19	947.68

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.03	0.04	0.03	0.09	0.01	0.01
Net Debt / Equity Ratio	-0.97	-0.99	-0.98	-0.94	-1.05	-1.00
Net Debt / EBITDA Ratio	2.30	1.91	3.88	2.29	1.99	3.10
Net Debt / FCF Ratio	2.96	2.55	5.57	2.93	2.84	3.71
Asset Turnover	0.00	0.01	0.00	0.01	0.01	0.00
Inventory Turnover	-	1.06	-	-	-	-
Quick Ratio	18.25	12.09	22.69	12.71	12.06	20.86
Current Ratio	18.60	12.32	23.04	13.07	12.45	21.55
Return on Equity (ROE)	-43.68%	-40.17%	-32.02%	-50.16%	-50.57%	-42.98%
Return on Assets (ROA)	-43.18%	-40.37%	-32.74%	-45.08%	-47.75%	-40.30%
Return on Invested Capital (ROIC)	-2186.03%	-2937.91%	-1238.12%	-2579.91%	-	-6403.21%
Return on Capital Employed (ROCE)	-46.03%	-42.78%	-34.47%	-48.61%	-50.91%	-42.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-12.58%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%
Total Shareholder Return	-12.58%	-16.43%	-39.11%	-11.71%	-35.24%	-26.23%

SEC Filings: 10-K · 10-Q